Medinotec Inc. Overview
Pro stress-test →Medinotec Inc. engages in the research and development, production, and sale of medical devices for the treatment of vascular and airway diseases in South Africa, the United States, and internationally. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, and silicone tracheal stents.
Strategic Profile
Pro stress-test →Medinotec is a US-based company with a primary investment in DISA Medinotec, a South African medical device manufacturing and distribution company, which is a global leader in tracheal non-occlusive airway dilation technology. U.S. sales reached $611,860 in fiscal 2026, about 6% of total sales, underscoring early but limited traction in the American market despite FDA 510(k) clearances for Trachealator and Outflo.
Competitive Landscape
Pro stress-test →Medinotec competes in specialized catheter and airway medical devices with limited direct competition in tracheal dilation. Primary competitors include larger diversified medical device manufacturers such as Boston Scientific, Cook Medical, and Medtronic in cardiology and vascular segments. The company's niche positioning in non-occlusive airway dilation provides a differentiation advantage, though global scale and distribution networks of larger competitors present ongoing competitive pressures.
Industry Context
Medinotec Inc. operates in Specialty cardiology and airway medical devices.
Key facts
Founded: 2021 · Headquarters: Johannesburg, South Africa · Employees: 48 · Revenue: ~$10.2M (fiscal 2026 estimated) · Market cap: N/A